The class of LOC100041079 inhibitors comprises synthetic molecules designed to interfere with specific enzymes and signaling molecules within cellular pathways. These compounds primarily target kinases, which are enzymes crucial for regulating a variety of cell functions, including growth and survival. By inhibiting these kinases, the compounds may indirectly affect the activity of LOC100041079. Some molecules within this class inhibit enzymes in the phosphoinositide 3-kinase (PI3K) family, impacting cell movement and growth. Other molecules focus on blocking the protein kinase Akt, which plays a role in metabolism, cell proliferation, and survival. There are also compounds that target specific members of the mitogen-activated protein kinase (MAPK) family, which includes enzymes that regulate cell differentiation and response to external stimuli.
A different set of inhibitors targets mTOR, a key regulator of cell growth that responds to environmental cues. By inhibiting mTOR, these molecules might impact LOC100041079's activity.Additionally, some inhibitors in this class are designed to block the action of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2), both of which are involved in controlling cell growth and survival.Lastly, multi-kinase inhibitors target various receptor tyrosine kinases (RTKs), which are implicated in cell signaling and proliferation. These inhibitors can affect multiple pathways and may alter the activity of LOC100041079 by this broad mechanism.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a steroidal metabolite of Penicillium funiculosum and acts as a potent phosphoinositide 3-kinase (PI3K) inhibitor, which may affect signaling pathways that LOC100041079 is involved in. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine is a synthetic tricyclic nucleoside that inhibits the activation of Akt, a serine/threonine kinase, potentially affecting downstream effects of LOC100041079. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a synthetic molecule functioning as a PI3K inhibitor, which may alter pathways interacting with LOC100041079. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a macrolide compound that inhibits mTOR, a key kinase that could be in the pathway where LOC100041079 functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an anthrapyrazolone inhibitor of c-Jun N-terminal kinase (JNK), affecting stress and inflammatory response pathways that might intersect with LOC100041079. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a pyridinyl imidazole that acts as a specific inhibitor of p38 MAP kinase, potentially altering signaling pathways involving LOC100041079. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a synthetic compound functioning as a MEK inhibitor, which may have an impact on the mitogen-activated protein kinase (MAPK) pathway associated with LOC100041079. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, which may disrupt signaling pathways that LOC100041079 is a part of. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib is another EGFR tyrosine kinase inhibitor, which might influence signaling networks where LOC100041079 is implicated. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Lapatinib is a dual tyrosine kinase inhibitor which targets both EGFR and HER2/neu, potentially modifying the function of pathways involving LOC100041079. | ||||||